Share: Facebook Twitter LinkedIn
Activity Provided By:

Evolve Medical Education LLC

Disease Modifying Glaucoma Treatments and Novel Therapies

Access Activity

Overview / Abstract:

Two new drugs in novel classes were approved recently for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. View this webinar, hosted by two glaucoma experts, to learn more about these new treatments, plus therapeutics pending approval by the FDA. A case series is also included in this presentation. This webcast with two thought leaders discusses these novel classes.

Expiration

Jul 31, 2022

Discipline(s)

Optometry / Ophthalmology CE

Format

Webinar / Webcast / Video

Credits / Hours

1

Accreditation

COPE,

Presenters / Authors / Faculty

JONATHAN S. MYERS, MD; DOUGLAS J. RHEE, MD

Sponsors / Supporters / Grant Providers

This Activity is supported by an unrestricted educational grant from Aerie.

Keywords / Search Terms

Evolve Medical Education LLC ophtalmology, optometry, glaucoma ,ocular hypertension, IOP Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map